Literature DB >> 1981067

Relative abuse liability of different benzodiazepines in drug abusers.

R R Griffiths1, B Wolf.   

Abstract

There is a convergence of data from various sources suggesting that there are meaningful differences among the benzodiazepines with respect to their attractiveness as drugs of abuse for drug abusers. Laboratory studies of subjective and reinforcing effects in drug abusers, interviews with drug abusers, clinical judgment of medical professionals, and epidemiological studies all indicate that diazepam, in particular, has a greater abuse liability than many of the other benzodiazepines. Some of the available data also suggest that lorazepam and alprazolam are more diazepam-like in having relatively high abuse liability, while oxazepam, halazepam, and possibly chlordiazepoxide, are relatively low in this regard. These differences in abuse liability among benzodiazepines are analogous to the widely recognized differences in abuse liability within the barbiturate class that have proved to be important in helping guide clinicians' drug prescribing practices.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981067

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  22 in total

1.  Ramelteon: a novel hypnotic indicated for the treatment of insomnia.

Authors:  Gary K Zammit
Journal:  Psychiatry (Edgmont)       Date:  2007-09

2.  Setting the record straight.

Authors:  R Shandera
Journal:  Can Fam Physician       Date:  1996-05       Impact factor: 3.275

Review 3.  A Review of Alprazolam Use, Misuse, and Withdrawal.

Authors:  Nassima Ait-Daoud; Allan Scott Hamby; Sana Sharma; Derek Blevins
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

4.  First demonstration that brain CYP2D-mediated opiate metabolic activation alters analgesia in vivo.

Authors:  Kaidi Zhou; Jibran Y Khokhar; Bin Zhao; Rachel F Tyndale
Journal:  Biochem Pharmacol       Date:  2013-04-23       Impact factor: 5.858

5.  Gabapentin Abuse in a Patient with Comorbid Mood and Substance Use Disorders.

Authors:  Oleg V Tcheremissine; Durga Prasad Bestha
Journal:  Innov Clin Neurosci       Date:  2016-08-01

6.  Self-injection of barbiturates, benzodiazepines and other sedative-anxiolytics in baboons.

Authors:  R R Griffiths; R J Lamb; C A Sannerud; N A Ator; J V Brady
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Subjective and behavioral effects of diazepam depend on its rate of onset.

Authors:  H de Wit; S Dudish; J Ambre
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  Addiction to benzodiazepines.

Authors:  C Salzman
Journal:  Psychiatr Q       Date:  1998

9.  Oral self-administration of triazolam, diazepam and ethanol in the baboon: drug reinforcement and benzodiazepine physical dependence.

Authors:  N A Ator; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 10.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.